Shareholders that lost money on Telix Pharmaceuticals Ltd.(TLX) Urged to Join Class Action – Contact Levi & Korsinsky to Learn More

Levi & Korsinsky, LLP notifies investors in Telix Pharmaceuticals Ltd. (“Telix Pharmaceuticals Ltd.” or the “Company”) (NASDAQ: TLX) of a class action securities lawsuit. https://mma.prnewswire.com/media/2280334/Levi_and_Korsinsky_Logo.jpg CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Telix Pharmaceuticals Ltd. investors who were adversely affected by alleged securities fraud between February 21, 2025 and August 28, […]

CarMax, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information – KMX

Levi & Korsinsky, LLP notifies investors in CarMax, Inc. (“CarMax, Inc.” or the “Company”) (NYSE: KMX) of a class action securities lawsuit. https://mma.prnewswire.com/media/2280334/Levi_and_Korsinsky_Logo.jpg CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of CarMax, Inc. investors who were adversely affected by alleged securities fraud between June 20, 2025 and November 5, 2025. Follow the

Synopsys, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before December 30, 2025 to Discuss Your Rights – SNPS

Levi & Korsinsky, LLP notifies investors in Synopsys, Inc. (“Synopsys, Inc.” or the “Company”) (NASDAQ: SNPS) of a class action securities lawsuit. https://mma.prnewswire.com/media/2280334/Levi_and_Korsinsky_Logo.jpg CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Synopsys, Inc. investors who were adversely affected by alleged securities fraud between December 4, 2024 and September 9, 2025. Follow the

Investors in MoonLake Immunotherapeutics Should Contact Levi & Korsinsky Before December 15, 2025 to Discuss Your Rights – MLTX

Levi & Korsinsky, LLP notifies investors in MoonLake Immunotherapeutics (“MoonLake” or the “Company”) (NASDAQ: MLTX) of a class action securities lawsuit. https://mma.prnewswire.com/media/2280334/Levi_and_Korsinsky_Logo.jpg CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of MoonLake investors who were adversely affected by alleged securities fraud between March 10, 2024 and September 29, 2025. Follow the link below

WatchMeGrow Appoints PB&J TV Founder Bobby Franzo as Chief Executive Officer

Leadership transition strengthens company's position as the category leader in early education technology and AI-powered safety solutions WatchMeGrow (“WMG” or the “Company”), the leading AI-powered SaaS platform providing video and business intelligence analytics to the childhood education, youth enrichment and petcare verticalsannounced today the appointment of Bobby Franzo, formerly COO of WMG and Founder of

Ataccama solidifies data trust leadership with investment from Snowflake Ventures

BOSTON, Dec. 09, 2025 (GLOBE NEWSWIRE) — Ataccama, the agentic data trust company, today announced a strategic investment from Snowflake Ventures. The funding deepens the companies' existing partnership and reflects a shared commitment to delivering trusted, explainable data that drives enterprise AI, advanced analytics, and regulatory compliance across the Snowflake AI Data Cloud. As AI

CentralReach Strengthens Executive Leadership Team for its Next Phase of Growth

Fort Lauderdale, FL, Dec. 09, 2025 (GLOBE NEWSWIRE) — CentralReach, a leading provider of Autism and IDD Care software for ABA, multidisciplinary, and special education, today announced the appointments of Kimberly Gerard as Chief Financial Officer and Samantha Goldman as Chief Marketing Officer, further strengthening its executive leadership team and setting the stage for strong

ST Math Research Underscores Elevated Academic Achievement for Texas Students

Five years of research reveals repeated acceleration for elementary and middle school students onSTAAR assessments with exceptional benefit for SPED learners MIND Education, the leader in neuroscience-driven mathematics instruction, released the findings from MIND Research Institute's dual research effort in Texas. The two studies-the annual Texas Education Agency (TEA) Longitudinal Study and the new Matched

Independent Actuarial Review Validates Goodpath Claims Analysis, Showing 32 Percent Reduction in Employer Medical Costs

— Havarti Risk confirms Goodpath's integrative care model produces $1,937 in annual medical-claims savings per member; additional Goodpath data highlight comparable savings and outcomes across employer groups Goodpath, the leading virtual provider of whole-person care for chronic conditions, today announced new actuarial data confirming that its integrative care programs deliver substantial cost savings and measurable

Scroll to Top